Compounded semaglutide vs brand name Wegovy: what is the real difference?

Short answer: Wegovy (Novo Nordisk) is an FDA‑approved, clinically tested semaglutide product for chronic weight management with strict manufacturing controls, labeled dosing, and safety data. “Compounded semaglutide” is made by compounding pharmacies from active drug powder or bulk substance and is not the FDA‑approved product — it can be cheaper but carries greater uncertainty about purity, dose accuracy, sterility, stability, and safety.

Key differences

• Regulatory status and evidence

  • Wegovy: FDA‑approved for weight loss after randomized clinical trials showing safety and effectiveness, with an approved label describing dosing, side effects, and monitoring.
  • Compounded semaglutide: not FDA‑approved as a Wegovy substitute and generally lacks the same clinical trial data supporting safety and weight‑loss claims.

• Manufacturing quality and testing

  • Wegovy: produced under GMPs by Novo Nordisk with lot testing, stability data, and clear labeling.
  • Compounded: quality depends on the pharmacy. Some reputable compounding pharmacies follow USP standards and test batches, but others may not provide the same assurance. There is higher risk of contamination, incorrect dosing, or degraded peptide.

• Dose accuracy and delivery device

  • Wegovy: comes in prefilled pens calibrated for the approved step‑up dosing (up to 2.4 mg weekly).
  • Compounded: may be supplied in vials, syringes, or custom pens. Dosing errors are more likely if the pharmacy or prescriber/patient handling isn’t expert.

• Safety monitoring and adverse‑event data

  • Wegovy: known safety profile and post‑marketing surveillance.
  • Compounded: adverse events may be underreported; unknown impurities could cause unexpected harms.

• Cost and access

  • Wegovy: expensive and insurance coverage varies, though Novo Nordisk offers patient support/savings programs for eligible patients.
  • Compounded: often cheaper, which is why many people consider it — but cost savings come with tradeoffs in certainty and oversight.

FDA/legal points

• The FDA has warned against marketed compounded substitutes for approved weight‑loss drugs because they may not be safe or effective. Compounding is legally allowed for patient‑specific prescriptions, but compounding pharmacies may not be appropriate when an approved product exists and is available.

If you’re considering compounded semaglutide — practical precautions

• Prefer a US FDA‑registered 503B outsourcing facility or a well‑credentialed 503A pharmacy that:
  • Follows USP <797>/<800> sterile compounding standards,
  • Has independent sterility and potency testing and can provide Certificates of Analysis,
  • Is accredited (look for PCAB accreditation or equivalent) and has good reviews from local clinicians.
• Ask the pharmacy where they source the active ingredient, for batch testing results, sterility testing, and clear instructions for storage and administration.
• Beware of online sellers that won’t provide testing data or that ship from unknown overseas manufacturers.
• Ensure your prescriber is involved and monitors you for effectiveness and side effects.

Alternatives and other brand options

• Wegovy (Novo Nordisk): preferred if you want the approved, studied option and device.
• Ozempic (Novo Nordisk): semaglutide for diabetes; some patients use it off‑label for weight loss at different doses but it is not the 2.4 mg Wegovy label dose.
• Zepbound (tirzepatide, Eli Lilly): another FDA‑approved option for weight management (different drug class with robust efficacy data).
• Talk with your clinician about insurance coverage, manufacturer savings programs (Novo Nordisk offers Wegovy support and savings programs), coupons (GoodRx), or patient assistance programs before choosing a compounded product.

Bottom line If you can access and afford Wegovy (or another FDA‑approved weight‑loss drug), that’s the safer, evidence‑based choice. If cost or access forces you to consider compounded semaglutide, only use a reputable, well‑audited compounding pharmacy/503B outsourcing facility, get batch test documentation, and involve your prescriber for close monitoring.